Dynamic Chart
1 day+6.56%
1 week+1.54%
Current month-5.71%
1 month-15.92%
3 months-22.92%
6 months-26.77%
Current year-17.11%
More quotes
1 week
4 515.00
Extreme 4515
5 690.00
1 month
4 515.00
Extreme 4515
6 300.00
Current year
4 515.00
Extreme 4515
6 500.00
1 year
4 515.00
Extreme 4515
8 490.00
3 years
2 465.00
Extreme 2465
9 380.00
5 years
2 465.00
Extreme 2465
9 380.00
10 years
2 465.00
Extreme 2465
9 380.00
More quotes
Director TitleAgeSince
Chief Executive Officer 50 2022-08-21
Chief Tech/Sci/R&D Officer 55 -
Chief Tech/Sci/R&D Officer 53 -
Manager TitleAgeSince
Director/Board Member 57 -
Director/Board Member 50 2021-12-31
Director/Board Member 53 -
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+6.56%+1.54%-34.00% - 51.58M
-1.43%-2.09%+34.33%-0.46% 48.19B
-2.94%+0.42%-7.93%-17.76% 35.38B
+0.39%+1.30%+5.06%+23.81% 26.25B
-1.83%-3.06%-32.72%-28.37% 15.47B
+2.22%-0.03%+66.39%+73.56% 15.77B
-2.95%-9.48%-64.62%-80.83% 11.9B
-2.25%-5.80%+0.57%-34.69% 10.8B
-7.52%-5.51%+0.45%+87.46% 10.02B
+4.17%+15.13% - - 11.21B
Average -0.60%-0.74%-3.61%+2.84% 18.51B
Weighted average by Cap. -1.33%-0.49%+7.41%+1.35%
See all sector performances
Logo Progen Co., Ltd.
Progen Co Ltd is a Korea-based company principally engaged in the researching and developing new drugs. The Company produces metabolic disease treatment drugs, immune disease treatment drugs, immune anticancer drugs, and others. The Company was established in 1998.
Employees
-
More about the company
Date Price Change Volume
25-02-11 5,280.00 +6.56% 28,103
25-02-10 4,955.00 +1.43% 1,611
25-02-07 4,885.00 +1.14% 10,825
25-02-06 4,830.00 -6.58% 8,282
25-02-05 5,170.00 -0.58% 9,377

End-of-day quote Korea S.E., February 10, 2025

More quotes
  1. Stock Market
  2. Equities
  3. A296160 Stock